Shao‐Hao Chen

1.3k total citations
80 papers, 890 citations indexed

About

Shao‐Hao Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Shao‐Hao Chen has authored 80 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 22 papers in Surgery. Recurrent topics in Shao‐Hao Chen's work include Prostate Cancer Treatment and Research (23 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Bladder and Urothelial Cancer Treatments (15 papers). Shao‐Hao Chen is often cited by papers focused on Prostate Cancer Treatment and Research (23 papers), Prostate Cancer Diagnosis and Treatment (18 papers) and Bladder and Urothelial Cancer Treatments (15 papers). Shao‐Hao Chen collaborates with scholars based in China. Shao‐Hao Chen's co-authors include Ning Xu, Xue‐Yi Xue, Qing‐Shui Zheng, Yong Wei, Yu‐Peng Wu, Zhi‐Bin Ke, Yun‐Zhi Lin, Jin‐Bei Huang, Xiaodong Li and Hai Cai and has published in prestigious journals such as PLoS ONE, The Science of The Total Environment and International Journal of Molecular Sciences.

In The Last Decade

Shao‐Hao Chen

77 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shao‐Hao Chen China 19 442 375 252 186 159 80 890
Orhan G. Yigitbasi Türkiye 18 286 0.6× 303 0.8× 94 0.4× 187 1.0× 95 0.6× 49 982
Fang-Jian Zhou China 17 188 0.4× 382 1.0× 99 0.4× 396 2.1× 156 1.0× 46 858
Tomoaki Takai Japan 17 207 0.5× 597 1.6× 455 1.8× 126 0.7× 80 0.5× 37 937
R. Küfer Germany 12 217 0.5× 205 0.5× 89 0.4× 265 1.4× 100 0.6× 36 694
Ursula Kuehs Germany 14 196 0.4× 165 0.4× 83 0.3× 251 1.3× 99 0.6× 36 517
Norma Alonzo Palma United States 11 251 0.6× 223 0.6× 164 0.7× 340 1.8× 64 0.4× 28 746
Brent F.G. Treiger United States 10 276 0.6× 329 0.9× 147 0.6× 122 0.7× 50 0.3× 11 763
Tobias Engl Germany 13 150 0.3× 227 0.6× 80 0.3× 265 1.4× 129 0.8× 25 791
Bridget Charbonneau United States 13 332 0.8× 200 0.5× 118 0.5× 57 0.3× 30 0.2× 17 795
Isamu Tachibana United States 10 85 0.2× 253 0.7× 139 0.6× 163 0.9× 65 0.4× 41 567

Countries citing papers authored by Shao‐Hao Chen

Since Specialization
Citations

This map shows the geographic impact of Shao‐Hao Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shao‐Hao Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shao‐Hao Chen more than expected).

Fields of papers citing papers by Shao‐Hao Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shao‐Hao Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shao‐Hao Chen. The network helps show where Shao‐Hao Chen may publish in the future.

Co-authorship network of co-authors of Shao‐Hao Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shao‐Hao Chen. A scholar is included among the top collaborators of Shao‐Hao Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shao‐Hao Chen. Shao‐Hao Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Fei, Yu‐Peng Wu, Zhi‐Bin Ke, et al.. (2024). Identification of neutrophil extracellular traps (NETs)-related molecular clusters in prostate cancer: Implications for predicting biochemical recurrence. International Immunopharmacology. 146. 113908–113908. 3 indexed citations
3.
Wei, Zongjie, Xuesong Bai, Shao‐Hao Chen, et al.. (2024). A radiomics-based interpretable machine learning model to predict the HER2 status in bladder cancer: a multicenter study. Insights into Imaging. 15(1). 262–262. 6 indexed citations
4.
5.
Chen, Shao‐Hao, Ye‐Hui Chen, Qing‐Shui Zheng, et al.. (2024). A Novel Classification System of Renal Hilar Tumors for Surgical Guidance: Technique, Outcome, and Safety. Annals of Surgical Oncology. 31(9). 5794–5803. 1 indexed citations
6.
Chen, Ye‐Hui, Hang Chen, Tingting Lin, et al.. (2023). ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes. Cell & Bioscience. 13(1). 38–38. 4 indexed citations
7.
Chen, Hang, Jia‐Yin Chen, Shao‐Hao Chen, et al.. (2023). Exploring Novel Genome Instability-associated lncRNAs and theirPotential Function in Pan-Renal Cell Carcinoma. Combinatorial Chemistry & High Throughput Screening. 27(12). 1788–1807. 1 indexed citations
8.
Chen, Shao‐Hao, Shaoming Chen, Yong Wei, et al.. (2023). Head-to-head comparisons of 68Ga-PSMA-11 and 18F-FDG PET/CT in evaluating patients with upper tract urothelial carcinoma: a prospective pilot study. International Urology and Nephrology. 55(11). 2753–2764. 3 indexed citations
9.
Wu, Yu‐Peng, Zhi‐Bin Ke, Ye‐Hui Chen, et al.. (2021). Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells. Cell Death and Disease. 12(4). 302–302. 20 indexed citations
10.
Chen, Lü, Zhi‐Bin Ke, Shao‐Hao Chen, et al.. (2021). Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients. International Journal of General Medicine. Volume 14. 6325–6342. 1 indexed citations
11.
Xu, Ning, Yu‐Peng Wu, Hubin Yin, et al.. (2020). SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis. Journal of Cancer Research and Clinical Oncology. 146(8). 1953–1969. 23 indexed citations
12.
Xu, Ning, Zhi‐Bin Ke, Xiaodan Lin, et al.. (2020). Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis. Cancer Cell International. 20(1). 302–302. 31 indexed citations
13.
Wu, Yu‐Peng, Zhi‐Bin Ke, Fei Lin, et al.. (2020). Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis. Pathology - Research and Practice. 216(10). 153109–153109. 13 indexed citations
14.
Chen, Shao‐Hao, Fei Lin, Zhi‐Bin Ke, et al.. (2020). An immune-related lncRNA prognostic model in papillary renal cell carcinoma: A lncRNA expression analysis. Genomics. 113(1). 531–540. 7 indexed citations
15.
Xu, Ning, Yu‐Peng Wu, Zhi‐Bin Ke, et al.. (2019). Risk factors of developing visceral metastases at diagnosis in prostate cancer patients. Translational Cancer Research. 8(3). 928–938. 3 indexed citations
16.
Xu, Ning, Yu‐Peng Wu, Zhi‐Bin Ke, et al.. (2019). Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data. Journal of Translational Medicine. 17(1). 311–311. 51 indexed citations
17.
Wei, Yong, Yu‐Peng Wu, Shao‐Hao Chen, et al.. (2018). Impact of Obesity on Long-Term Urinary Incontinence after Radical Prostatectomy: A Meta-Analysis. BioMed Research International. 2018. 1–9. 24 indexed citations
18.
Xu, Ning, Yu‐Peng Wu, Xiaodong Li, et al.. (2018). Upregulation of Arp2 expression is associated with the prognosis and prediction of lymph node metastasis in bladder urothelial carcinoma. Cancer Management and Research. Volume 10. 503–511. 5 indexed citations
19.
Zheng, Qing‐Shui, Shao‐Hao Chen, Yu‐Peng Wu, et al.. (2018). Increased Paxillin expression in prostate cancer is associated with advanced pathological features, lymph node metastases and biochemical recurrence. Journal of Cancer. 9(6). 959–967. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Orhan G. Yigitbasi Breakdown of academic impact, for papers by Fang-Jian Zhou Breakdown of academic impact, for papers by Tomoaki Takai Breakdown of academic impact, for papers by R. Küfer Breakdown of academic impact, for papers by Ursula Kuehs Breakdown of academic impact, for papers by Norma Alonzo Palma Breakdown of academic impact, for papers by Brent F.G. Treiger Breakdown of academic impact, for papers by Tobias Engl Breakdown of academic impact, for papers by Bridget Charbonneau Breakdown of academic impact, for papers by Isamu Tachibana
Rankless by CCL
2026